Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKoçyiğit-Kaymakçıoğlu, Bedia
dc.contributor.authorYazıcı, Senem Sinem
dc.contributor.authorTok, Fatih
dc.contributor.authorDikmen, Miriş
dc.contributor.authorEnGür, Selin
dc.contributor.authorOruç-Emre, Emine Elçin
dc.contributor.authorIyidoğan, Ayşegül
dc.date.accessioned2019-10-19T14:16:33Z
dc.date.available2019-10-19T14:16:33Z
dc.date.issued2019
dc.identifier.issn1570-1808
dc.identifier.issn1875-628X
dc.identifier.urihttps://dx.doi.org/10.2174/1570180815666180816124102
dc.identifier.urihttps://hdl.handle.net/11421/13183
dc.descriptionWOS: 000464613300006en_US
dc.description.abstractBackground: Hydrazones, one of the important classes of organic molecules, are pharmaceutical agents comprising -CO-NH-N=CH- group in the structure therefore and exhibiting significant biological activity. Methods: 5-Chloro-N'-[(substituted)methylidene] pyrazine-2-carbohydrazide (3a-g) and their Pd(II) complexes (4a-h) were synthesized and investigated in vitro anticancer activity on A549, Caco2 cancer and normal 3T3 fibroblast cell lines, using the MTT assay. Results: Anticancer activity screening results revealed that some compounds showed remarkable cytotoxic effect. Among them, 5-chloro-N'-[(4-hydroxyphenyl)methylidene] pyrazine-2-carbohydrazide (3c) displayed higher cytotoxic activity against A549 cancer cell line than the reference drug cisplatin. Conclusion: Compound 3c showed high cytotoxic activity against A549 cancer cell line but it showed low cytotoxic effect against normal 3T3 fibroblast cell line. Antiproliferative and antimetastatic effects of 3c were determined by the real-time monitoring of cell proliferative system (RTCA DP). The cell proliferation, metastatic and invasive activities of A549 cells were decreased due to increased concentration of 3c.en_US
dc.description.sponsorshipMarmara University Scientific Research Commission [SAG-C-YLP-191212-0350, SAG-D-100615-0258]en_US
dc.description.sponsorshipThis study was supported by Marmara University Scientific Research Commission [Grant SAG-C-YLP-191212-0350 and SAG-D-100615-0258]. We thank Prof. Dr. Ahmet Karadag and Huseyin Akbas for TGA analysis.en_US
dc.language.isoengen_US
dc.publisherBentham Science Publ LTDen_US
dc.relation.isversionof10.2174/1570180815666180816124102en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHydrazoneen_US
dc.subjectMetal-Complexesen_US
dc.subjectAnticancer Activityen_US
dc.subjectMtt Assayen_US
dc.subjectReal-Time Monitoringen_US
dc.subjectProliferative Systemen_US
dc.titleSynthesis and Anticancer Activity of New Hydrazide-hydrazoncs and Their Pd(II) Complexesen_US
dc.typearticleen_US
dc.relation.journalLetters in Drug Design & Discoveryen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmakoloji Anabilim Dalıen_US
dc.identifier.volume16en_US
dc.identifier.issue5en_US
dc.identifier.startpage522en_US
dc.identifier.endpage532en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.contributor.institutionauthorDikmen, Miriş


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster